Alexandros Vakalopoulos

This inventor holds 52 USPTO granted patents and 31 published patent applications, plus 2 CIPO patents and 45 EPO patents, primarily in Pharmaceutical Chemistry (CPC class A61K). Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property Gmbh, Bayer Aktiengesellschaft. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandros Vakalopoulos. Retrieved from https://idiyas.com/inventor/alexandros-vakalopoulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52 (Patent Applications = 31)

% Patents Active = 26.9

CIPO Patents = 2 (Patent Applications = 16)

EPO Patents = 45 (Patent Applications = 60)

Average Co-Inventor Count = 8.7

ph-index = 8

Forward Citations = 198(Granted Patents)

Forward Citations (Not Self Cited) = 128(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Hiden, DE (2018)
Hilden, DE (2012 - 2024)

Company Filing History:

26 out of 387

Bayer Pharma Aktiengesellschaft

patents

25 out of 721

Bayer Intellectual Property Gmbh

patents

6 out of 12,268

Bayer Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Pyrazolo Derivatives

Imidazo Compounds

Muscarinic Receptor Modulators

Carboxylic Acids

Amino-Substituted Compounds

Dicyanopyridines

Triazines

Fused Pyrimidines

Aryl-Naphthyridine

Prodrugs

Cardiovascular Treatments

Heteroaryl-Substituted

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12595247 - Substituted pyrazolo piperidine carboxylic acids (2026-04-07),

2. 12195448 - Substituted pyrazolo piperidine carboxylic acids (2025-01-14),

3. 11912692 - Substituted S-alaninate derivatives (2024-02-27),

4. 11472803 - 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof (2022-10-18),

5. 10927109 - 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof (2021-02-23),

6. 10662185 - Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use (2020-05-26),

7. 10519154 - 7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof (2019-12-31),

8. 10435403 - Positive allosteric modulators of muscarinic M2 receptor (2019-10-08),

9. 10292970 - Heteroaryl-substituted imidazo[1,2-A]pyridines and their use (2019-05-21),

10. 10214526 - Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof (2019-02-26),

11. 10174021 - Substituted pyrazolo[1,5-A]pyridines and their use (2019-01-08),

12. 10150773 - N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases (2018-12-11),

13. 10052312 - Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use (2018-08-21),

14. 9776997 - 3-aryl-substituted imidazo[1,2-A]pyridines and their use (2017-10-03),

15. 9771360 - Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use (2017-09-26),

Title: Inventor Alexandros Vakalopoulos

Introduction: Alexandros Vakalopoulos is a renowned inventor based in Hilden, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Alexandros Vakalopoulos holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Vakalopoulos has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Alexandros Vakalopoulos has collaborated with top engineers, scientists, and designers to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: In conclusion, Alexandros Vakalopoulos continues to push the boundaries of innovation, leaving a lasting legacy in the world of technology and engineering.

Profile summary based on public USPTO records.